New European patent approval for Episurf Medical
The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint”, is within the area of 3D-based assessment of joint lesions, and complements the company’s previously approved patents within that field. “Episurf Medical’s damage marking technology constitutes a central part of the Episealer® implant system as well as the Epioscopy® joint visualisation system. Our visualisation of joint damage, which